XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity and Accumulated Other Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (loss)
Balance beginning (in shares) at Dec. 31, 2020   62,545,275      
Balance beginning at Dec. 31, 2020 $ 122 $ 6 $ 98,620 $ (98,888) $ 384
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Reclassification of stockholders' convertible notes payable (in shares)   2,049,191      
Reclassification of stockholders’ convertible notes payable 20,493   20,493    
Reclassification of redeemable convertible preferred stock warrant liability (in shares)   5,554,440      
Reclassification of redeemable convertible preferred stock warrant liability 54,267   54,267    
Business Combination, net of redemptions and equity issuance costs of $37 million (in shares)   66,481,545      
Business Combination, net of redemptions and equity issuance costs of $37 million 385,410 $ 7 385,403    
Reclassification of equity to liability related to earn out provisions of Business Combination (see note 13) (203,082)   (203,082)    
Common stock issued upon exercise of stock options (in shares)   55,762      
Common stock issued upon exercise of stock options 55   55    
Stock-based compensation 4,172   4,172    
Net income 8,960     8,960  
Other comprehensive income (loss) 1,092       1,092
Ending balance at Jun. 30, 2021 271,489 $ 13 359,928 (89,928) 1,476
Ending balance (in shares) at Jun. 30, 2021   136,686,213      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity issuance costs 37,000        
Balance beginning (in shares) at Mar. 31, 2021   62,601,037      
Balance beginning at Mar. 31, 2021 (52,301) $ 6 99,302 (152,459) 850
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Reclassification of stockholders' convertible notes payable (in shares)   2,049,191      
Reclassification of stockholders’ convertible notes payable 20,493   20,493    
Reclassification of redeemable convertible preferred stock warrant liability (in shares)   5,554,440      
Reclassification of redeemable convertible preferred stock warrant liability 54,267   54,267    
Business Combination, net of redemptions and equity issuance costs of $37 million (in shares)   66,481,545      
Business Combination, net of redemptions and equity issuance costs of $37 million 385,410 $ 7 385,403    
Reclassification of equity to liability related to earn out provisions of Business Combination (see note 13) (203,082)   (203,082)    
Stock-based compensation 3,545   3,545    
Net income 62,531     62,531  
Other comprehensive income (loss) 626       626
Ending balance at Jun. 30, 2021 271,489 $ 13 359,928 (89,928) 1,476
Ending balance (in shares) at Jun. 30, 2021   136,686,213      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity issuance costs 37,000        
Balance beginning (in shares) at Dec. 31, 2021   141,301,569      
Balance beginning at Dec. 31, 2021 303,510 $ 16 361,542 (56,797) (1,251)
Ending balance at Mar. 31, 2022 308,394 $ 16 362,770 (49,451) (4,941)
Ending balance (in shares) at Mar. 31, 2022   141,418,989      
Balance beginning (in shares) at Dec. 31, 2021   141,301,569      
Balance beginning at Dec. 31, 2021 303,510 $ 16 361,542 (56,797) (1,251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of stock options (in shares)   944,716      
Common stock issued upon exercise of stock options 268 $ (2) 270    
Immediately vested common stock awards (in shares)   132,649      
Stock-based compensation 3,041   3,041    
Net income 54,277     54,277  
Other comprehensive income (loss) (10,188)       (10,188)
Ending balance at Jun. 30, 2022 350,908 $ 14 364,853 (2,520) (11,439)
Ending balance (in shares) at Jun. 30, 2022   142,378,934      
Balance beginning (in shares) at Mar. 31, 2022   141,418,989      
Balance beginning at Mar. 31, 2022 308,394 $ 16 362,770 (49,451) (4,941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of stock options (in shares)   827,296      
Common stock issued upon exercise of stock options 234 $ (2) 236    
Immediately vested common stock awards (in shares)   132,649      
Stock-based compensation 1,847   1,847    
Net income 46,931     46,931  
Other comprehensive income (loss) (6,498)       (6,498)
Ending balance at Jun. 30, 2022 $ 350,908 $ 14 $ 364,853 $ (2,520) $ (11,439)
Ending balance (in shares) at Jun. 30, 2022   142,378,934